In vitro findings reveal Telomir-1's dual action: targeting DNA methylation switches and cutting into the Wnt "fuel line" ...

An aging expert thinks humans can live for 20,000 years—and he might not be crazy. There's one major key to unlocking extreme ...

Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt", or the "Company"), a social innovation platform accelerating promising health innovations, today announced an update on its wholly owned subsidiary Adimune, Inc.

A research group led by the University of Osaka has discovered that the DNA repair enzyme Polβ plays a crucial role in ...

ER-300 improves key biomarkers of liver health in an animal model of MASH These data, along with additional ER-100 ...

Cancer research organization City of Hope has co-led a study to show that characterizing genetic material close to chromosomes predicts how mutated, cancer-causing genes reprogram DNA and alter the ...

OpenAI and Retro Biosciences have developed GPT-4b micro, an AI specializing in protein redesign for regenerative medicine.

This model aims to enhance the efficiency of cellular reprogramming, a process that can potentially reverse aspects of aging.

Biotech Anti-aging biotech NewLimit raises $130M to push liver reprogramming med into clinic By Darren Incorvaia May 6, 2025 11:00am aging Longevity Biotech cell aging liver disease ...

The U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC) has expanded the ...